Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guideline Platform
  3. Maternity
  4. Back
  5. COVID-19 (Maternity)
  6. Covid-19 Obstetric HDU Level Admission (856)
Announcements and latest updates

Welcome to the Right Decision Service (RDS) newsletter for August 2024.

  1. Contingency planning for RDS outages

Following the recent RDS outages, Tactuum and the RDS team have been reviewing the learning from these incidents. We are committed to doing all we can to ensure a positive outcome by strengthening the RDS to make it fully robust and clinically resilient for the future.

We would like to invite you to a webinar on 26th September 3-4 pm on national and local contingency planning for future RDS outages.  Tactuum and the RDS team will speak about our business continuity plans and the national contingency arrangements we are putting in place. This will also be a space to share local contingency plans, ideas and existing good practice. We would also like to gather your views on who we should send communications to in the event of future outages.

I have sent a meeting request for this date to all editors – please accept or decline to indicate attendance, and please forward on to relevant contacts. You can also contact Olivia.graham@nhs.scot directly to register your interest in participating.

 

2.National  IV fluid prescribing  calculator

This UK CA marked calculator is now live at https://righdecisions.scot.nhs.uk/ivfluids  . It has been developed by a multiprofessional steering group of leads in IV fluids management, as part of the wider Modernising Patient Pathways Programme within the Centre for Sustainable Delivery.  It aims to address a known cause of clinical error in hospital settings, and we hope it will be especially useful to the new junior doctors who started in August.

Please do spread the word about this new calculator and get in touch with any questions.

 

  1. New toolkits

The following toolkits are now live;

  1. Updated guidance on current and future Medical Device Regulations

We have updated and simplified this guidance within our standard operating procedures. We have clarified the guidance on how to determine whether an RDS tool is a medical device, and have provided an interactive powerpoint slideset to steer you through the process.

 

  1. Guide to six stages of RDS toolkit development

We have developed a guide to support editors and toolkit leads through the process of scoping, designing, delivering, quality assuring and implementing a new RDS toolkit.  We hope this will help in project planning and in building shared understanding of responsibilities throughout the full development process.  The guide emphasises that the project does not end with launch of the new toolkit. Implementation, communication and evaluation are ongoing activities throughout the lifetime of the toolkit.

 

  1. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:
  • Thursday 5 September 1-2 pm
  • Wednesday 24 September 4-5 pm
  • Friday 27 September 12-1 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

7 Evaluation projects

Dr Stephen Biggart from NHS Lothian has kindly shared with us the results of a recent survey of use of the Edinburgh Royal Infirmary of Edinburgh Anaesthesia toolkit. This shows that the majority of consultants are using it weekly or monthly, mainly to access clinical protocols, with a secondary purpose being education and training purposes. They tend to find information by navigating by specialty rather than keyword searching, and had some useful recommendations for future development, such as access to quick reference guidance.

We’d really appreciate you sharing any other local evaluations of RDS in this way – it all helps to build the evidence base for impact.

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

 

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

Covid-19 Obstetric HDU Level Admission (856)

Warning
Please report any inaccuracies or issues with this guideline using our online form

Inform consultant obstetrician and consultant anaesthetist on admission

Transmission

Droplets produced when an infected person breathes or coughs carry viruses that may be inhaled. Droplets spread about 1-2 metres. Droplets remain infectious when they settle on surfaces, can contaminate hands and then be carried to nose or mouth. Incubation time 1 - 14 days, average 5 days. Duration of infectivity unknown – up to 21 days?

PPE

Contact precautions (gloves, waterproof apron, eye protection, FRSM) - minimal acceptable standard.

Clinical features

65-80% cough; 45% febrile on presentation (85% febrile during illness); 20-40% dyspnoea; 15% URTI symptoms; 10% GI symptoms. Symptom duration up to 3 weeks. Respiratory failure / pneumonia occurs after 5 - 7 days of symptoms

Investigations

FBC, U&E, LFTs, CRP, Coag (use COVID blood set on trakcare)

ABG are not req’d for initiating O2 Rx. ABGs should be measured as standard in deteriorating or drowsy patients if results would potentially alter management

Nasal and throat swab and if producing sputum, a sputum sample are mandatory – send both on admission. Repeat at 24hrs if -ve and ongoing high clinical suspicion

Other as clinically appropriate e.g. blood/urine/stool cultures, troponin, ECG, viral gargle if influenza-like illness

CXR: compulsory. May be normal or show hazy bilateral, peripheral opacities or other condition.

Consider CT if would change Rx (eg ?PE)

Laboratory features

Renal failure, leukopenia/lymphopenia (80%), ↑AST/ALT/bilirubin, ↑D-dimer, ↑ CRP, ↑ LDH, ↑ferritin

Management

AirwayAnaesthetic assessment on admission
BreathingContinuous SpO2, hourly RR, CXR
Art line
O2 to maintain SpO2 ≥ 94%
If SpO2<94% on 4L NC or 35% O2 or rising RR (≥30) - Immediate anaesthetic review, ABG and discussion with ICU / obstetrician / neonatology to plan immediate care

Circulation


Remember left lat tilt

HR, BP, CRT, catheterise, hourly UOP
Fluid resus on admission if required with 250ml boluses of Hartmanns then review
Accurate hourly fluid balance
Aim even fluid balance after initial resus
Echo if unstable
DisabilityAVPU / GCS / BM
ExposureHourly temp
Ensure all relevant cultures sent
Don’t forget other common causes of sepsis
LMWH as protocol
FetusConsider delivery on a case by case basis based on maternal condition, disease trajectory and gestation of fetus (consult with neonatology)
Fetal monitoring as directed by obstetricians
Steroids / MgSO4 as required for fetus

Other - The RECOVERY trial states that steroid therapy should be considered for 10 days or to hospital discharge, whichever is sooner, for adults unwell with COVID-19 and requiring oxygen (in pregnant adults, use oral prednisolone 40 mg once a day or intravenous hydrocortisone 80 mg twice a day).

Tocilizumab may be considered if SpO2<92% on air or requiring O2 and CRP ≥ 75 – discuss with a named consultant familiar with the management of covid pneumonitis within office hours - refer to PRM anaesthetic COVID guide and GGC guidance on Staffnet re exclusions / cautions. Data limited in pregnancy-consider risks vs benefits and discuss in multi-disciplinary forum.

Editorial Information

Last reviewed: 28/06/2022

Next review date: 30/06/2025

Author(s): Kerry Litchfield.

Version: 8.2

Approved By: Covid-19 Tactical Group (Acute)

Document Id: 856